Check-Cap Ltd Ord (CHEK) Stock Price, Quote & News

Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.

Industry: Diagnostics & Research

Sector: Healthcare

Website: check-cap.com

Address:

29 Abba Hushi Ave., P.O.Box 1271, Isfiya, Israel

SASknls Oct. 3 at 4:30 PM

$CHEK 0.70 before any merger

0 · Reply

moneyflow_trader Oct. 2 at 6:58 PM

$CHEK added

1 · Reply

Whisky87 Oct. 2 at 4:58 PM

$CHEK

0 · Reply

Igmon007 Oct. 2 at 4:20 AM

$CHEK I haven't been here since the trial failed and they decided to preserve the cash ($29M) for a potential merger two years ago. How did they burn through all that cash while trying to preserve it??? Just putting it in a CD would generate enough interest revenue to cover their expenses. I don't get it.

1 · Reply

Whisky87 Oct. 1 at 1:39 PM

$CHEK Volume dried up?

1 · Reply

simplifocused Oct. 1 at 10:04 AM

$CHEK carefully loading here for inevitable massive runs, in my opinion NFA

0 · Reply

simplifocused Oct. 1 at 7:25 AM

$CHEK Check Cap Ltd Stock (CHEK) Forecast The Check Cap Ltd (CHEK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $26.07, representing a +1129.86% increase from the current price of $2.12. The highest analyst price target is $25.77, and the lowest is $26.37 https://stockscan.io/stocks/CHEK/forecast NFA

0 · Reply

simplifocused Sep. 30 at 12:38 PM

$CHEK nfa

2 · Reply

jujujunjun Sep. 29 at 5:41 PM

0 · Reply

Tradingistheway Sep. 29 at 3:56 PM

$CHEK $5 $APP

0 · Reply

Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders

May 13, 2025, 7:31 AM EDT - 5 months ago

MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

May 8, 2025, 7:30 AM EDT - 5 months ago

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

Mar 25, 2024, 7:15 PM EDT - 1 year ago

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Dec 22, 2023, 10:36 AM EST - 1 year ago

SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

Dec 13, 2023, 12:37 PM EST - 1 year ago

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

Dec 8, 2023, 11:18 AM EST - 1 year ago

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

Dec 5, 2023, 3:42 PM EST - 1 year ago

CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

Nov 28, 2023, 11:56 AM EST - 2 years ago

Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

Nov 28, 2023, 11:42 AM EST - 2 years ago

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Nov 27, 2023, 8:00 AM EST - 2 years ago

Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Aug 16, 2023, 5:08 PM EDT - 2 years ago

Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Aug 4, 2023, 4:15 PM EDT - 2 years ago

Check-Cap Reports Second Quarter 2023 Financial Results

Jul 25, 2023, 10:22 AM EDT - 2 years ago

SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

Jun 6, 2023, 7:00 AM EDT - 2 years ago

Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce

May 11, 2023, 4:30 PM EDT - 2 years ago

Check-Cap Reports First Quarter 2023 Financial Results

Mar 31, 2023, 4:45 PM EDT - 2 years ago

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 21, 2023, 9:00 AM EDT - 2 years ago

Check-Cap Issues an Update to Shareholders

Nov 30, 2022, 8:30 AM EST - 3 years ago

Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

Aug 31, 2022, 8:00 AM EDT - 3 years ago

Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Jun 23, 2022, 8:30 AM EDT - 3 years ago

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Jun 1, 2022, 8:00 AM EDT - 3 years ago

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

May 11, 2022, 8:00 AM EDT - 3 years ago

Check-Cap Announces Initiation of the U.S. Pivotal Trial

Apr 7, 2022, 8:30 AM EDT - 3 years ago

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Mar 1, 2022, 8:30 AM EST - 3 years ago

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

Feb 7, 2022, 10:19 AM EST - 3 years ago

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

Feb 7, 2022, 8:30 AM EST - 3 years ago

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

Jan 5, 2022, 9:15 AM EST - 4 years ago

Check-Cap Issues Letter to Shareholders

Dec 23, 2021, 4:15 PM EST - 4 years ago

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

Nov 22, 2021, 8:00 AM EST - 4 years ago

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®

Nov 3, 2021, 8:30 AM EDT - 4 years ago

Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update

Nov 2, 2021, 8:30 AM EDT - 4 years ago

Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

Oct 18, 2021, 8:00 AM EDT - 4 years ago

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

Sep 1, 2021, 8:30 AM EDT - 4 years ago

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

Aug 5, 2021, 8:30 AM EDT - 4 years ago

Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update

Jun 30, 2021, 8:12 AM EDT - 4 years ago

Check-Cap Ltd. Announces $35 Million Registered Direct Offering

May 12, 2021, 8:00 AM EDT - 4 years ago

Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update

Mar 19, 2021, 7:00 AM EDT - 4 years ago

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 15, 2021, 7:34 AM EDT - 4 years ago

FDA Signs Off Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Technology

Mar 15, 2021, 7:00 AM EDT - 4 years ago

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

Jan 28, 2021, 10:44 AM EST - 5 years ago

Check-Cap: Come Back In A Year

Jul 23, 2020, 9:35 AM EDT - 5 years ago

Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds

May 27, 2020, 4:45 PM EDT - 5 years ago

Check-Cap Reports First Quarter 2020 Financial Results and Provides Corporate Update

Jul 9, 2019, 7:58 AM EDT - 6 years ago

Check-Cap Announces Final Results From Post-CE Approval Study Of C-Scan

SASknls Oct. 3 at 4:30 PM

$CHEK 0.70 before any merger

0 · Reply

moneyflow_trader Oct. 2 at 6:58 PM

$CHEK added

1 · Reply

Whisky87 Oct. 2 at 4:58 PM

$CHEK

0 · Reply

Igmon007 Oct. 2 at 4:20 AM

1 · Reply

Whisky87 Oct. 1 at 1:39 PM

$CHEK Volume dried up?

1 · Reply

simplifocused Oct. 1 at 10:04 AM

$CHEK carefully loading here for inevitable massive runs, in my opinion NFA

0 · Reply

simplifocused Oct. 1 at 7:25 AM

0 · Reply

simplifocused Sep. 30 at 12:38 PM

$CHEK nfa

2 · Reply

jujujunjun Sep. 29 at 5:41 PM

0 · Reply

Tradingistheway Sep. 29 at 3:56 PM

$CHEK $5 $APP

0 · Reply

TraderJay85 Sep. 29 at 12:51 AM

This week watch list with support/stop. $LBGJ .64 $ATYR .8020 @Blackberrys play $STKE 4.60 $CHEK 2.10 NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER.

0 · Reply

LegendaryCharts Sep. 28 at 3:16 PM

$PAVS Looks like they squeezing up this PAVS now, crazy buy blocks friday, Top watch for a premarket gapper ! $CHEK bullish reversal due for this $OCGN recent license agreement of OCU400 Modifier Gene Therapy $VSTD low float watching

0 · Reply

TraderJay85 Sep. 28 at 3:00 PM

$CHEK $CHEK hit my stop last week.. but is setting up beautifully again. 2.10 stop this time

0 · Reply

rangervs Sep. 26 at 12:51 PM

$WOLF still in this These types of situation’s can pop Kept a couple thousand fir the show $OPEN $CHEK $BSLK

1 · Reply

rangervs Sep. 25 at 3:09 PM

$OPEN $CHEK

0 · Reply

TraderJay85 Sep. 24 at 11:10 PM

$CHEK $CURX if any of my followerrs dont have $IXHL in their portfolio. you aint paying attention. this is my biggest position. must have!!!!

2 · Reply

TraderJay85 Sep. 22 at 7:42 PM

$CHEK $GORV $CHOW $RCT All these just need volume. all have under 5m float.

0 · Reply

rangervs Sep. 22 at 6:50 PM

$APLD $CHEK

0 · Reply

YouVSYou Sep. 22 at 6:12 PM

$CHEK on the brink

2 · Reply

Crypto9999 Sep. 22 at 6:10 PM

$CHEK One positive news article(imo) with outstanding shares and float so low…. 🚀 $5+++🧲🧲🧲🧲

0 · Reply

rangervs Sep. 22 at 3:16 PM

$BKKT nice! $CHEK

0 · Reply

sbn15 Sep. 22 at 2:44 PM

$CHEK or cash $$ :)

0 · Reply

Market Cap	13.28M
Revenue (ttm)	0.00
Net Income (ttm)	-25.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	115,000
Avg Vol	3,734,972
Day's Range	N/A - N/A
Shares Out	5.85M
Stochastic %K	39%
Beta	0.50
Analysts	Strong Buy
Price Target	$7.00